144 related articles for article (PubMed ID: 20847214)
1. Detection of the JAK2V617F mutation with the Ipsogen MutaScreen kit: absence of JAK2V617F does not mean absence of myeloproliferative neoplasm.
Peyro-Saint-Paul H; Hermitte F
Blood; 2010 Sep; 116(11):1994-5. PubMed ID: 20847214
[No Abstract] [Full Text] [Related]
2. JAK2 V617F "indeterminate" results by MutaScreen can be easily resolved using MutaQuant kits.
Hoteit RM; Shammaa DM; Mahfouz RA
Genet Test Mol Biomarkers; 2012 Feb; 16(2):146-9. PubMed ID: 21933004
[TBL] [Abstract][Full Text] [Related]
3. JAK2 V617F mutation detection: laboratory comparison of two kits using RFLP and qPCR.
Shammaa D; Bazarbachi A; Halas H; Greige L; Mahfouz R
Genet Test Mol Biomarkers; 2010 Feb; 14(1):13-5. PubMed ID: 19877761
[TBL] [Abstract][Full Text] [Related]
4. JAK2V617F mutation in patients with splanchnic vein thrombosis.
Xavier SG; Gadelha T; Pimenta G; Eugenio AM; Ribeiro DD; Gomes FM; Bonamino M; Zalcberg IR; Spector N
Dig Dis Sci; 2010 Jun; 55(6):1770-7. PubMed ID: 19690956
[TBL] [Abstract][Full Text] [Related]
5. [Usefulness of real-time semi-quantitative PCR, JAK2 MutaScreen kit for JAK2 V617F screening].
Chae H; Lee JH; Lim J; Jung SW; Kim M; Kim Y; Han K; Cho BS; Cho SG; Lee JW; Min WS
Korean J Lab Med; 2009 Jun; 29(3):243-8. PubMed ID: 19571623
[TBL] [Abstract][Full Text] [Related]
6. Hemichorea in a patient with JAK2V617F blood cells.
Lew J; Frucht SJ; Kremyanskaya M; Hoffman R; Mascarenhas J
Blood; 2013 Feb; 121(7):1239-40. PubMed ID: 23411735
[No Abstract] [Full Text] [Related]
7. The JAK2V617F mutation: no impact on circulating hematopoietic progenitors in myeloproliferative disorders.
Wappl M; Jaeger E; Kusec R; Schwarzinger I; Geissler K; Oehler L
Ann Hematol; 2008 Jun; 87(6):509-11. PubMed ID: 18180923
[No Abstract] [Full Text] [Related]
8. Clinical performance of JAK2 V617F mutation detection assays in a molecular diagnostics laboratory: evaluation of screening and quantitation methods.
Cankovic M; Whiteley L; Hawley RC; Zarbo RJ; Chitale D
Am J Clin Pathol; 2009 Nov; 132(5):713-21. PubMed ID: 19846812
[TBL] [Abstract][Full Text] [Related]
9. Clinical and biological characterization of patients with low (0.1-2%) JAK2V617F allele burden at diagnosis.
Lippert E; Mansier O; Migeon M; Denys B; Nilsson A; Rosmond C; Lodé L; Ugo V; Lascaux A; Bellosillo B; Martinez-Lopez J; Naguib D; Gachard N; Maroc N; Hermouet S
Haematologica; 2014 Jul; 99(7):e98-101. PubMed ID: 24837467
[No Abstract] [Full Text] [Related]
10. Failure of the Ipsogen MutaScreen kit to detect the JAK2 617V>F mutation in samples with additional rare exon 14 mutations: implications for clinical testing and report of a novel 618C>F mutation in addition to 617V>F.
Warshawsky I; Mularo F; Hren C; Jakubowski M
Blood; 2010 Apr; 115(15):3175-6. PubMed ID: 20395423
[No Abstract] [Full Text] [Related]
11. JAK2V617F somatic mutation in the general population: myeloproliferative neoplasm development and progression rate.
Nielsen C; Bojesen SE; Nordestgaard BG; Kofoed KF; Birgens HS
Haematologica; 2014 Sep; 99(9):1448-55. PubMed ID: 24907356
[TBL] [Abstract][Full Text] [Related]
12. JAK2V617F mutation for the early diagnosis of Ph- myeloproliferative neoplasms in patients with venous thromboembolism: a meta-analysis.
Dentali F; Squizzato A; Brivio L; Appio L; Campiotti L; Crowther M; Grandi AM; Ageno W
Blood; 2009 May; 113(22):5617-23. PubMed ID: 19273837
[TBL] [Abstract][Full Text] [Related]
13. Assessment of the interlaboratory variability and robustness of JAK2V617F mutation assays: A study involving a consortium of 19 Italian laboratories.
Perricone M; Palandri F; Ottaviani E; Angelini M; Bagli L; Bellesia E; Donati M; Gemmati D; Zucchini P; Mancini S; Marchica V; Trubini S; De Matteis G; Di Zacomo S; Favarato M; Fioroni A; Bolzonella C; Maccari G; Navaglia F; Gatti D; Toffolatti L; Orlandi L; Laloux V; Manfrini M; Galieni P; Giannini B; Tieghi A; Barulli S; Serino ML; Maccaferri M; Scortechini AR; Giuliani N; Vallisa D; Bonifacio M; Accorsi P; Salbe C; Fazio V; Gusella M; Toffoletti E; Salvucci M; Svaldi M; Gherlinzoni F; Cassavia F; Orsini F; Martinelli G
Oncotarget; 2017 May; 8(20):32608-32617. PubMed ID: 28427233
[TBL] [Abstract][Full Text] [Related]
14. Quantification of JAK2V617F mutation load by droplet digital PCR can aid in diagnosis of myeloproliferative neoplasms.
Zheng CF; Zhao XX; Chen XH; Liu Z; Wang WJ; Luo M; Ren Y; Wang HW
Int J Lab Hematol; 2021 Aug; 43(4):645-650. PubMed ID: 33973741
[TBL] [Abstract][Full Text] [Related]
15. Thrombosis in myeloproliferative neoplasms with JAK2V617F mutation.
Sun T; Zhang L
Clin Appl Thromb Hemost; 2013; 19(4):374-81. PubMed ID: 22826442
[TBL] [Abstract][Full Text] [Related]
16. Relationship between JAK2V617F mutation, allele burden and coagulation function in Ph-negative myeloproliferative neoplasms.
Hu L; Pu L; Ding Y; Li M; Cabanero M; Xie J; Zhou D; Yang D; Zhang C; Wang H; Zhai Z; Ru X; Li J; Xiong S
Hematology; 2017 Jul; 22(6):354-360. PubMed ID: 27976991
[TBL] [Abstract][Full Text] [Related]
17. Granulocyte whole exome sequencing and endothelial JAK2V617F in patients with JAK2V617F positive Budd-Chiari Syndrome without myeloproliferative neoplasm.
Helman R; Pereira WO; Marti LC; Campregher PV; Puga RD; Hamerschlak N; Chiattone CS; Santos FPS
Br J Haematol; 2018 Feb; 180(3):443-445. PubMed ID: 27650062
[No Abstract] [Full Text] [Related]
18. [Detection of JAK2V617F mutation in patients with myeloproliferative disorders with TaqMan-MGB probe].
Ruan GR; Chen SS; Li LD; Liu YR; Qin YZ; Li JL; Ma X; Wang FR; Jiang Q; Jiang B; Liu KY; Huang XJ
Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(34):2401-4. PubMed ID: 18036317
[TBL] [Abstract][Full Text] [Related]
19. Jakking up tumor registry reporting of the myeloproliferative neoplasms.
Selinger HA; Ma X
Am J Hematol; 2009 Feb; 84(2):124-6. PubMed ID: 19117021
[No Abstract] [Full Text] [Related]
20. A novel, highly sensitive and rapid allele-specific loop-mediated amplification assay for the detection of the JAK2V617F mutation in chronic myeloproliferative neoplasms.
Minnucci G; Amicarelli G; Salmoiraghi S; Spinelli O; Guinea Montalvo ML; Giussani U; Adlerstein D; Rambaldi A
Haematologica; 2012 Sep; 97(9):1394-400. PubMed ID: 22315499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
